A number of challenges are being faced by the pharmaceutical industry and this is making it difficult for them to register strong growth. Companies could survive through third party relationships. A combination of licensing collaboration and outsourcing deals would be ideal.
As per reports generated by Datamonitor, there are a number of opportunities in outsourcing manufacturing and drug discovery functions which could help in controlling falling returns and R&D productivity. .
The changing environment for pharmaceutical companies is putting a lot of pressure on them and these companies are relying on third parties and moving towards a network pharma model.
